APPs now drive 27% of U.S. | APPs now drive 27% of U.S. prescriptions and influence over half of treatment decisions—making them essential for pharma engagement. Download The APP Imperative to learn ...

Precision medicine is reshaping the landscape of clinical development, offering more advanced strategies to align therapies with individual biological variability. Recent research shows that drug ...

A significant portion of disease-relevant proteins remain “undruggable” by traditional therapeutic approaches, representing a major hurdle in drug discovery. Targeted protein degradation (TPD) is ...

Medical affairs is on the brink of transformation. Learn how AI is reshaping evidence generation, scientific engagement, and strategic planning. Get the roadmap to prepare your team for what's next ...

Discover how the vaginal microbiome impacts women’s health and how the OMNIgene™•VAGINAL kit empowers reliable, easy self-collection and preserves high-quality microbial DNA/RNA for up to 30 days.

Join an executive panel exploring innovations in sterile filling for drug-device delivery, strategic collaborations, and CDMO value redefined to meet evolving market needs. Gain insights into ...

Are you ready to revolutionize quality control and deviation management? Discover how AI can empower your organization with process automation, workflow visibility, real-time reporting, and analytics ...

Discover the latest pharma quality and manufacturing trends. Digital transformation in pharma is a key move to remain viable in a marketplace that is demanding more personalisation, more quickly than ...

In addition to their traditional roles, today's Life Sciences finance executives are facing many challenges, including complex supply chains and legal entity structures, regulatory reporting demands, ...

Dive into the captivating world of social video with this valuable summary that captures key expert insights from our recent webinar. Explore the dynamic shifts in demographics and culture that have ...

The complexity of supply chains in the life sciences industry has grown significantly, requiring advanced technologies and applications to handle demand shifts, supply constraints, and global ...

Contracts can be difficult to maintain and track. In highly regulated industries such as the biotech pharma space, not only can a contract be complicated but so can the multitude of company ...